3 results

• Many Patients Receive No Benefit From Cholesterol Drugs: Study

  August 10, 2020

  Irvin Jackson

  A new study finds that cholesterol guidelines have not led to a decrease in cardiovascular deaths, even when they lowered cholesterol levels to target numbers.

• Repatha, Similar Cholesterol Drugs, Overpriced For Benefits They Provide: Study

  August 25, 2017

  Irvin Jackson

  A new class of cholesterol drugs that includes Repatha and Praluent may be significantly overpriced in the U.S. when you look at the benefits they provide, according to the findings of a new study.

• Praluent, Repatha Costs Outweigh Health Benefits: Study

  September 14, 2015

  Irvin Jackson

  A new report warns that the cholesterol drugs Praluent and Repatha may be too expensive for the modest benefits they give to patients.